Trials / Recruiting
RecruitingNCT06773650
Proper Dietary Management, Follow-up, and Lactase Enzyme Supplementation for Lactose Intolerance
Lactose Intolerance: a Guide to Proper Dietary Management, Follow-up, and Lactase Enzyme Supplementation
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 385 (estimated)
- Sponsor
- European Institute of Oncology · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Lactose intolerance (LI) is considered the clinical syndrome caused by lactose malabsorption (LM). It is possible to identify four causes of lactase deficiency defining four different types of LM: primary (genetic), secondary (acquired), congenital (alactasia), and developmental (in premature infants, so reversible). The aim of this protocol is to investigate through an anonymous online survey the knowledge of the Italian population on clinical, pathophysiological, diagnostic and therapeutic issues of lactose intolerance. Data collected will be divulgated through a publication for both people with IL and nutritionists, enriched with tables and flow charts, to improve the knowledge on lactose intolerance and to support people suffering from this condition. The results of this survey will guide subjects suspected of suffering from lactose intolerance towards a correct diagnosis and a better management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Completion of online survey | The online survey aims to reach a representative sample of the Italian population to identify their knowledge regarding LI |
Timeline
- Start date
- 2025-01-08
- Primary completion
- 2026-01-01
- Completion
- 2026-01-01
- First posted
- 2025-01-14
- Last updated
- 2025-01-14
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06773650. Inclusion in this directory is not an endorsement.